What is Microtrace?
Microtrace operates as a highly specialized materials analysis laboratory, distinguished by its expertise in the characterization and identification of trace substances and single particles. Utilizing advanced microscopy and sophisticated microchemical techniques, the firm provides essential analytical support for criminal and civil litigation, alongside critical services for the pharmaceutical, food, environmental, and manufacturing industries. With a legacy spanning over three decades, the company has established itself as an international authority in forensic art analysis, contaminant identification, and consumer complaint resolution. Its market position is defined by a rigorous scientific methodology that addresses complex, high-value problems where precision is paramount.
How much funding has Microtrace raised?
Microtrace has raised a total of $348K across 2 funding rounds:
Debt
$150K
Debt
$198K
Debt (2020): $150K with participation from PPP
Debt (2021): $198K led by PPP
Key Investors in Microtrace
PPP
Public-Private Partnership
What's next for Microtrace?
With the recent infusion of capital, Microtrace is well-positioned to scale its operational capacity and further integrate cutting-edge analytical technologies into its service suite. The firm's strategic roadmap likely involves expanding its footprint in the pharmaceutical and environmental sectors, where the demand for high-fidelity particle analysis is accelerating. By maintaining its commitment to forensic excellence, Microtrace is poised to capitalize on the increasing complexity of industrial and legal disputes, ensuring that its specialized services remain the gold standard for clients requiring definitive, evidence-based insights. The company's focus will remain on enhancing its technical infrastructure to support long-term scalability and market leadership.
See full Microtrace company page
